NURIA
VEGAS REVENGA
University of the Witwatersrand
Johannesburgo, SudáfricaPublications en collaboration avec des chercheurs de University of the Witwatersrand (7)
2022
-
Correction to: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis (Diagnostics 2021, 11, 2363)
Diagnostics
-
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
Frontiers in Immunology, Vol. 13
2021
-
Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis
Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2801-2807
-
Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
Arthritis Research and Therapy, Vol. 23, Núm. 1
-
Moderate and high disease activity predicts the development of carotid plaque in rheumatoid arthritis patients without classic cardiovascular risk factors: Six years follow-up study
Journal of Clinical Medicine, Vol. 10, Núm. 21
-
SCORE2 assessment in the calculation of cardiovascular risk in patients with rheumatoid arthritis
Diagnostics, Vol. 11, Núm. 12
2020
-
Carotid plaques as predictors of cardiovascular events in patients with Rheumatoid Arthritis. Results from a 5-year-prospective follow-up study
Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 6, pp. 1333-1338